EP Patent

EP4017502A1 — Polymorphic forms of deoxycytidine, compositions comprising the same and uses

Assigned to Ucb Biosciences Inc · Expires 2022-06-29 · 4y expired

What this patent protects

Polymorphic forms of deoxycytidine and methods for preparing the same are provided herein. Also provided are compositions comprising polymorphic forms of deoxycytidine and at least one residual solvent, as well as methods of treating mitochondrial diseases using said compositions…

USPTO Abstract

Polymorphic forms of deoxycytidine and methods for preparing the same are provided herein. Also provided are compositions comprising polymorphic forms of deoxycytidine and at least one residual solvent, as well as methods of treating mitochondrial diseases using said compositions.

Drugs covered by this patent

Patent Metadata

Patent number
EP4017502A1
Jurisdiction
EP
Classification
—
Expires
2022-06-29
Drug substance claim
No
Drug product claim
No
Assignee
Ucb Biosciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.